REG - GlaxoSmithKline PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">GSK.L</Origin>

GSKAnnouncement

13/10/2017 16:26

RNS Number : 6100T
GlaxoSmithKline PLC
13 October 2017
GlaxoSmithKline plc(the'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mrs V A Whyte
b)
Position/status
Company Secretary
c)
Initial notification/
amendment 
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Natureofthetransaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017. 
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
15.2659
55
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-13
f)
Placeofthe transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr I W Whyte
b)
Position/status
PCA of Mrs V A Whyte (Company Secretary)
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Natureofthetransaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017. 
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
15.2659
407
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-13
f)
Placeofthe transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mrs D Connor
b)
Position/status
PCA of Mr R G Connor (President, Global Manufacturing & Supply)
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Natureofthetransaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017. 
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
15.2659
259
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-13
f)
Placeofthe transaction
London Stock Exchange (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHEXLFFDBFFFBD